Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors

NCT ID: NCT05994209

Last Updated: 2025-07-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE1

Total Enrollment

189 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-04

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Use of vaping products (e.g., electronic nicotine delivery systems, e-cigarettes) has been increasing rapidly, particularly among teens and young adults. With limited information on the long-term effects of vaping products, health information about vaping has been somewhat unclear in regards to associated health risks. Teens and young adults may be reluctant to disclose their use of vaping products to parents or health providers and instead turn to social media to share and seek out information regarding vaping risks and cessation supports. Thus, our current proposal outlines the use of social media to identify teens and young adults socially networking about vaping, the use of an online chatbot screen to evaluate individual cessation support needs, and the use of a digital intervention system to support vaping cessation. The mobile intervention used in this study is based on a widely-used evidence-based mobile intervention for combustible smoking (i.e., quitSTART) and has been adapted for vaping and young adults to include an in-app chatbot to guide users to tailored content and to motivate and encourage their cessation efforts. We aim to integrate our social media recruitment and online screening approach to connect individuals with this mobile app intervention, and will conduct a randomized controlled trial to evaluate user engagement with and preliminary efficacy of the digital intervention on reducing vaping behaviors among teens and young adults.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nicotine Vaping Nicotine Use Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group

Nationwide resource referral and intervention waitlist

Group Type NO_INTERVENTION

No interventions assigned to this group

Experimental Group A: Mobile App Intervention

quitSTART Mobile Application Adapted for Vaping Cessation Among Young Adults

Group Type EXPERIMENTAL

quitSTART Mobile Application

Intervention Type DEVICE

Mobile application with educational content, motivational messages, self-monitoring, and tips for managing cravings to support vaping cessation among young adults.

Experimental Group B: Mobile App Intervention with Embedded Chatbot Feature

quitSTART Mobile Application Adapted for Vaping Cessation Among Young Adults Including Embedded Chatbot Feature

Group Type EXPERIMENTAL

quitSTART Mobile Application

Intervention Type DEVICE

Mobile application with educational content, motivational messages, self-monitoring, and tips for managing cravings to support vaping cessation among young adults.

Chatbot Feature in quitSTART Mobile Application

Intervention Type BEHAVIORAL

In-App chatbot feature emedded into quitSTART mobile application to motivate vaping cessation and support app navigation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

quitSTART Mobile Application

Mobile application with educational content, motivational messages, self-monitoring, and tips for managing cravings to support vaping cessation among young adults.

Intervention Type DEVICE

Chatbot Feature in quitSTART Mobile Application

In-App chatbot feature emedded into quitSTART mobile application to motivate vaping cessation and support app navigation.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* US Resident
* English Speaking
* Have daily access to a smartphone
* Current vaping product user (P30D)
* Identified as socially networking about a desire to quit vaping and/or experiencing negative health outcomes due to vaping
* Vaping product user only (i.e., not using vaping as a means to support combustible smoking cessation)
Minimum Eligible Age

15 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The University of Texas Health Science Center, Houston

OTHER

Sponsor Role collaborator

University of South Carolina

OTHER

Sponsor Role collaborator

National Institute on Drug Abuse (NIDA)

NIH

Sponsor Role collaborator

Washington University School of Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Washington University in St. Louis, School of Medicine

St Louis, Missouri, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Patricia Cavazos-Rehg, PhD

Role: CONTACT

314-362-2152

Erin Kasson, MSW

Role: CONTACT

314-362-9003

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Erin Kasson

Role: primary

314-246-9156

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R34DA054725

Identifier Type: NIH

Identifier Source: secondary_id

View Link

1R34DA054725-01A1

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Adolescent Inpatient Tobacco and ENDS Intervention
NCT05936099 ACTIVE_NOT_RECRUITING NA
Development of UP2UTobacco for High School Youth
NCT05396911 ACTIVE_NOT_RECRUITING NA